BF
SLXP

BOK Financial’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BOK Financial’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-18,461
Closed -$3.19M – 921
2015
Q1 		$3.19M Buy
18,461
+32
+0.2% +$4.7K 0.11% 224
2014
Q4 		$2.12M Sell
18,429
-2,904
-14% -$352K 0.07% 279
2014
Q3 		$3.33M Sell
21,333
-723
-3% -$105K 0.11% 210
2014
Q2 		$2.72M Sell
22,056
-18,687
-46% -$2.07M 0.09% 257
2014
Q1 		$4.22M Buy
40,743
+6,795
+20% +$696K 0.14% 165
2013
Q4 		$3.05M Sell
33,948
-6,370
-16% -$508K 0.1% 217
2013
Q3 		$2.7M Sell
40,318
-7,317
-15% -$504K 0.1% 232
2013
Q2 		$3.15M Buy
+47,635
New +$2.72M 0.12% 178

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BOK Financial's SLXP Position: Q2 2015 in Review

BOK Financial sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 18,461 shares — an estimated $3.19M sold.

BOK Financial first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $4.22M in Q1 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • BOK Financial reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • BOK Financial sold 18,461 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $3.19M.
  • BOK Financial first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • BOK Financial's SALIX PHARMACEUTICALS LTD DEL position peaked at $4.22M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BOK Financial's 13F filing for Q2 2015, filed 13 Aug 2015.